tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Neurotech’s NTI164 to be Highlighted at Rett Syndrome Scientific Meeting
PremiumCompany AnnouncementsNeurotech’s NTI164 to be Highlighted at Rett Syndrome Scientific Meeting
3M ago
Neurotech International’s NTI164 Shows Promising PK Study Results
Premium
Company Announcements
Neurotech International’s NTI164 Shows Promising PK Study Results
3M ago
Neurotech International Advances in Pediatric Neurological Treatments
Premium
Company Announcements
Neurotech International Advances in Pediatric Neurological Treatments
4M ago
Neurotech International Announces Executive Director Resignation
PremiumCompany AnnouncementsNeurotech International Announces Executive Director Resignation
5M ago
Neurotech’s NTI164 Receives EU Orphan Drug Designation for Rett Syndrome
Premium
Company Announcements
Neurotech’s NTI164 Receives EU Orphan Drug Designation for Rett Syndrome
5M ago
Neurotech Retracts Market Opportunity Statement
Premium
Company Announcements
Neurotech Retracts Market Opportunity Statement
5M ago
Neurotech Secures EMA Positive Opinion for NTI164 in Rett Syndrome
PremiumCompany AnnouncementsNeurotech Secures EMA Positive Opinion for NTI164 in Rett Syndrome
6M ago
Director of Neurotech International Ltd. Increases Stake with Options Acquisition
Premium
Company Announcements
Director of Neurotech International Ltd. Increases Stake with Options Acquisition
6M ago
Neurotech International Issues New Unquoted Equity Options
Premium
Company Announcements
Neurotech International Issues New Unquoted Equity Options
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100